These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38166057)

  • 1. Spiritual health practitioners' contributions to psychedelic assisted therapy: A qualitative analysis.
    Peacock C; Mascaro JS; Brauer E; Zarrabi AJ; Dunlop BW; Maples-Keller JL; Grant GH; Raison CL; Rab F; Palitsky R
    PLoS One; 2024; 19(1):e0296071. PubMed ID: 38166057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of Integrating Spiritual, Existential, Religious, and Theological Components in Psychedelic-Assisted Therapies.
    Palitsky R; Kaplan DM; Peacock C; Zarrabi AJ; Maples-Keller JL; Grant GH; Dunlop BW; Raison CL
    JAMA Psychiatry; 2023 Jul; 80(7):743-749. PubMed ID: 37256584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies.
    Niles H; Fogg C; Kelmendi B; Lazenby M
    BMC Palliat Care; 2021 Dec; 20(1):191. PubMed ID: 34930220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The perceptions of cancer health-care practitioners in New Zealand and the USA toward psychedelic-assisted therapy with cancer patients: A cross-sectional survey.
    Reynolds LM; Barnett B; Weleff J; Morunga E; Wells A; Stack A; Akroyd A; Hoeh N; Sundram F; Muthukumaraswamy S; Lawrence N; Evans WJ
    Palliat Support Care; 2022 Nov; ():1-10. PubMed ID: 36325995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping an Agenda for Psychedelic-Assisted Therapy Research in Patients with Serious Illness.
    Beaussant Y; Tulsky J; Guérin B; Schwarz-Plaschg C; Sanders JJ;
    J Palliat Med; 2021 Nov; 24(11):1657-1666. PubMed ID: 33848208
    [No Abstract]   [Full Text] [Related]  

  • 6. Defining the Roles and Research Priorities for Psychedelic-Assisted Therapies in Patients with Serious Illness: Expert Clinicians' and Investigators' Perspectives.
    Beaussant Y; Sanders J; Sager Z; Tulsky JA; Braun IM; Blinderman CD; Bossis AP; Byock I
    J Palliat Med; 2020 Oct; 23(10):1323-1334. PubMed ID: 32233936
    [No Abstract]   [Full Text] [Related]  

  • 7. Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry.
    Barber GS; Dike CC
    Psychiatr Serv; 2023 Aug; 74(8):838-846. PubMed ID: 36987705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.
    Barnett BS; Parker SE; Weleff J
    Int J Drug Policy; 2022 Jan; 99():103473. PubMed ID: 34624734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychedelic-assisted therapies: The past, and the need to move forward responsibly.
    Gardner J; Carter A; O'Brien K; Seear K
    Int J Drug Policy; 2019 Aug; 70():94-98. PubMed ID: 31136924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice.
    Gobbi G; Inserra A; Greenway KT; Lifshitz M; Kirmayer LJ
    Transcult Psychiatry; 2022 Oct; 59(5):718-724. PubMed ID: 36263521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The need for establishing best practices and gold standards in psychedelic medicine.
    Feduccia A; Agin-Liebes G; Price CM; Grinsell N; Paradise S; Rabin DM
    J Affect Disord; 2023 Jul; 332():47-54. PubMed ID: 37003433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing meaning: hedonistic perspectives on the therapeutic use of psychedelic-assisted meaning enhancement.
    Miceli McMillan R
    J Med Ethics; 2021 Oct; 47(10):701-705. PubMed ID: 33148774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying Key Lessons from the Hospice and Palliative Care Movement to Inform Psychedelic-Assisted Therapy.
    Miller M; Rosa WE; Doerner Rinaldi A; Addicott K; Spence D; Beaussant Y
    Psychedelic Med (New Rochelle); 2023 Sep; 1(3):124-129. PubMed ID: 37753521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychedelic-Assisted Group Therapy: A Systematic Review.
    Trope A; Anderson BT; Hooker AR; Glick G; Stauffer C; Woolley JD
    J Psychoactive Drugs; 2019; 51(2):174-188. PubMed ID: 30950777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Taking your place at the table": an autoethnographic study of chaplains' participation on an interdisciplinary research team.
    Kestenbaum A; James J; Morgan S; Shields M; Hocker W; Rabow M; Dunn LB
    BMC Palliat Care; 2015 May; 14():20. PubMed ID: 25934500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interest in receiving psychedelic-assisted therapy among marginalized women: Implications and findings from a community-based study in Canada.
    Argento E; Goldenberg S; Deering K; Lavalley J; Braschel M; Bingham B; Shannon K
    Drug Alcohol Depend Rep; 2022 Jun; 3():100044. PubMed ID: 36845985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.
    Lowe H; Toyang N; Steele B; Grant J; Ali A; Gordon L; Ngwa W
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Healthcare Workers' Perceptions toward Psychedelic-Assisted Therapy: A Preliminary Investigation.
    Reynolds LM; Akroyd A; Sundram F; Stack A; Muthukumaraswamy S; Evans WJ
    Int J Environ Res Public Health; 2021 Aug; 18(15):. PubMed ID: 34360453
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.